< Back to previous page
Researcher
Jeroen Dekervel
- Disciplines:Analysis of next-generation sequence data, Single-cell data analysis, Cancer diagnosis, Cancer therapy
Affiliations
- Digestive Oncology (Division)
Member
From1 Aug 2022 → Today - Clinical Digestive Oncology (Division)
Member
From1 Oct 2018 → Today - Hepatology Research Unit (Division)
Member
From1 Oct 2012 → 2 Oct 2016
Projects
1 - 8 of 8
- Fighting therapy resistance in liver cancer with Hippo pathway inhibitorsFrom1 Oct 2024 → TodayFunding: Fund Recuperation Fiscal Exemption
- Neoadjuvant therapy in the treatment of esophageal adenocarcinoma: one size doesn’t fit allFrom14 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Multicenter validation trial of [18F]AlF-FAPI-74 for PET imaging of cancer-associated fibroblasts through fibroblast activation protein inhibitors (FAPI) in digestive tumorsFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Refinement of candidate predictive biomarkers for response to immune checkpoint inhibition in hepatocellular carcinomaFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- [18F]AlF-NOTA-octreotide PET imaging of the somatostatin receptor in neuroendocrine tumors: comparison with [68Ga]Ga-DOTATATE and evaluation of routine clinical use.From3 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Personalized multimodal treatment for resectable esophageal cancer by detecting minimal residual disease (MRD) using circulating tumor DNA (ctDNA):From11 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- SAFIR-ABC10: molecular screening for precision medicine in advanced biliary cancersFrom1 Jan 2022 → TodayFunding: Foundations, funds and other with scientific goal
- The search for biomarkers in systemic treatment of advanced hepatocellular carcinoma.From1 Oct 2019 → 1 Oct 2023Funding: FWO Strategic Basic Research Grant
Publications
1 - 10 of 58
- Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population(2024)
Authors: Jeroen Dekervel
- Clinical and Molecular Variables Associated With Early Progression to Checkpoint Inhibitors in MSI-High Metastatic Colorectal Cancer: A Retrospective Cohort Study.(2024)
Authors: Frederik Peeters, Jeroen Dekervel
Pages: 230 - 237.e1 - Clinical impact of using [18F]AlF-NOTA-octreotide PET/CT instead of [68Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial(2024)
Authors: Hannes Leupe, Jeroen Dekervel, Frederik Cleeren, Michel Koole, Chris Verslype, Christophe Deroose
- Applications of single-cell multi-omics in liver cancer(2024)
Authors: Frederik Peeters, Sarah Cappuyns, Chris Verslype, Diether Lambrechts, Jeroen Dekervel
- Immunotherapy Rechallenge After Checkpoint Inhibitor Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review(2024)
Authors: Jeroen Dekervel
Pages: 194 - 197 - Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants(2024)
Authors: Jeroen Dekervel, Gert De Hertogh, Hilde Brems, Eric Legius
- Gastrointestinal issue: Advances in gastrointestinal oncology(2024)
Authors: Jeroen Dekervel
- Controversies in upper GI oncology: first-line systemic treatment in MASLD-associated HCC(2024)
Authors: Jeroen Dekervel
- Controversies in upper GI oncology: maintenance treatment in pancreatic cancer(2024)
Authors: Jeroen Dekervel
- Fulminant ectopic Cushing's syndrome caused by metastatic small intestine neuroendocrine tumour - a case report and review of the literature.(2024)
Authors: Christophe Deroose, Tania Roskams, Jeroen Dekervel
Pages: 48 - 51